Advanced cell therapies with and without scaffolds

Biotechnology Journal

Volumn 6, Issue 12, 2011, Pages 1437-1453

  Demirbag, Birsen ^a   Huri, Pinar Y ^a,b   Kose, Gamze T ^a,c   Buyuksungur, Arda ^a   Hasirci, Vasif ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Biomaterials; Regenerative medicine; Scaffold free; Scaffolds; Tissue engineering

Indexed keywords

BIOLOGICALLY ACTIVE MOLECULES; CELL FUNCTIONS; CELL SHEET ENGINEERING; CELL SOURCES; CELL THERAPY; GROWTH FACTOR; HEART MUSCLES; IN-VITRO; REGENERATIVE MEDICINE; SCAFFOLD MATERIALS; SCAFFOLD-FREE; SURFACE FUNCTIONALIZATION; TISSUE SUBSTITUTE;

BIOMATERIALS; BLOOD VESSELS; CELLS; HISTOLOGY; SCAFFOLDS; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

GROWTH FACTOR; TISSUE SCAFFOLD;

BIOLOGICAL ACTIVITY; BLOOD VESSEL; BONE; CARTILAGE; CELL FUNCTION; CELL THERAPY; HEART MUSCLE; NERVOUS TISSUE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SOFT TISSUE; SURFACE PROPERTY; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TISSUE THERAPY;

EID: 83455263361     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201100261     Document Type: Review

References (104)

1. Datta, N., Holtorf, H. L., Sikavitsas, V. I., Jansen, J. A. et al., Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 2005, 26, 971-978.
2. Cao, H., Chen, X., Huang, L., Shao, Z., Electrospinning of reconstituted silk fiber from aqueous silk fibroin solution. Mater. Sci. Eng. C. 2009, 29, 2270-2274.
3. Santos, M. I., Tuzlakoglu, K., Fuchs, S., Gomes, M. E. et al., Endothelial cell colonization and angiogenic potential of combined nano- and micro-fibrous scaffolds for bone tissue engineering. Biomaterials 2008, 29, 4306-4313.
4. He, Q., Zhao, Y., Chen, B., Xiao, Z. et al., Improved cellularization and angiogenesis using collagen scaffolds chemically conjugated with vascular endothelial growth factor. Acta Biomater. 2011, 7, 1084-1093.
5. Yilgor, P., Tuzlakoglu, K., Reis, R. L., Hasirci, N. et al., Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009, 30, 3551-3559.
6. Liao, G., Chen, L., Zeng, X., Zhou, X. et al., Electrospun poly(L-lactide)/poly(e-caprolactone) blend fibers and their cellular response to adipose-derived stem cells. J. Appl. Polym. Sci. 2011, 120, 2154-2165.
7. Yu, H. S., Jang, J. H., Kim, T. I., Lee, H. H. et al., Apatite-mineralized polycaprolactone nanofibrous web as a bone tissue regeneration substrate. J. Biomed. Mater. Res. 2009, 88, 747-754.
8. Yang, X., Shah, J. D., Wang, H., Nanofiber enabled layer-by-layer approach toward three-dimensional tissue formation. Tissue Eng. A. 2009, 15, 945-956.
9. Hynes, R. O., Zhao, Q., The evolution of cell adhesion. J. Cell Biol. 2000, 24, 89-96.
10. Pierschbacher, M. D., Ruoslahti, E., Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309, 30-33.
11. Gil, E. S., Mandal, B. B., Park, S.-H., Marchant, J. K. et al., Helicoidal multi-lamellar features of RGD-functionalized silk biomaterials for corneal tissue engineering. Biomaterials 2010, 31, 8953-8963.
12. Deming, T. J., Methodologies for preparation of synthetic block copolypeptides: Materials with future promise in drug delivery. Adv. Drug. Deliv. Rev. 2002, 54, 1145-1155.
13. Bell, B. F., Schuler, M., Tosatti, S., Textor, M. et al., Osteoblast response to titanium surfaces functionalized with extracellular matrix peptide biomimetics. Clin. Oral. Implants Res. 2011, 22, 865-872.
14. Yucel, D., Kose, G. T., Hasirci, V., Tissue engineered, guided nerve tube consisting of aligned neural stem cells and astrocytes. Biomacromolecules 2010, 3584-3591.
15. Lam, M. T., Sim, S., Zhu, X., Takayama, S., The effect of continuous wavy micropatterns on silicone substrates on the alignment of skeletal muscle myoblasts and myotubes. Biomaterials 2006, 27, 4340-4347.
16. Richardson, T. P., Murphy, W. L., Mooney, D. J., Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit. Rev. Eukaryot. Gene Exp. 2001, 11, 47-58.
17. Salvay, D. M., Shea, L. D., Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol. BioSyst. 2006, 2, 36-48.
18. Chen, R. R., Mooney, D. J., Polymeric growth factor delivery strategies for tissue engineering. Pharm. Res. 2003, 20, 1103-1112.
19. Patel, Z. S., Young, S., Tabata, Y., Jansen, J.A. et al., Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008, 43, 931-940.
20. Simmons, C. A., Alsberg, E., Hsiong, S., Kim, W. J. et al., Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004, 562-569.
21. Temenoff, J. S., Mikos, A. G., Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000, 21, 431-440.
22. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J. et al., Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7, 211-228.
23. Hwang, N. S., Kim, M. S., Sampattavanich, S., Baek, J. H., Effects of three-dimensional culture and growth factors on the chondrogenic differentiation of murine embryonic stem cells. Stem Cells 2006, 24, 284-291.
24. Holland, T. A., Mikos, A. G., Advances in drug delivery for articular cartilage. J. Control. Release 2003, 86, 1-14.
25. Masuda, K., An, H. S., Growth factors and the intervertebral disc. Spine J. 2004, 4, 330S-340S.
26. Gaissmaier, C., Koh, J. L., Weise, K., Growth and differentiation factors for cartilage healing and repair. Injury Int. J. Care Injured 2008, 39S1, S88-S96.
27. Vivien, D., Galera, P., Lebrun, E., Loyau, G. et al., Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes. J. Cell Physiol. 1990, 143, 534-545.
28. Jakob, M., Demarteau, O., Schafer, D., Hintermann, B. et al., Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J. Cell Biochem. 2001, 81, 368-377.
29. Lohmann, C. H., Schwartz, Z., Niederauer, G. G., Carnes, D. L. et al., Pretreatment with platelet derived growth factor-BB modulates the ability of costochondral resting zone chondrocytes incorporated into PLA/PGA scaffolds to form new cartilage in vivo Biomaterials 2000, 21, 49-61.
30. Caplan, A. I., Elyaderani, M., Mochizuki, Y., Wakitani, S. et al., Principles of cartilage repair and regeneration. Clin.Orthop.Rel.Res. 1997, 342, 254-269.
31. Sechriest, V. F., Miao, Y. J., Niyibizi, C., Westerhausen-Larson, A. et al., GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesis. J.Biomed.Mater.Res. 2000, 49, 534-541.
32. Tan, H., Chu, C. R., Payne, K. A., Marra, K. G., Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 2009, 30, 2499-2506.
33. Kose, G. T., Korkusuz, F., Ozkul, A., Soysal, Y. et al., Tissue engineered cartilage on collagen and PHBV matrices. Biomaterials 2005, 26, 5187-5197.
34. Svensson, A., Nicklasson, E., Harrah, T., Panilaitis, B. et al., Bacterial cellulose as a potential scaffold for tissue engineering of cartilage. Biomaterials 2005, 26, 419-431.
35. Ma, P. X., Langer, R., Morphology and mechanical function of long-term in vitro engineered cartilage. J. Biomed Mater Res. 1999, 44, 217-221.
36. Li, W. J., Jiang, Y. J., Tuan, R. S., Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng. 2006, 12, 1775-1785.
37. Grande, D. A., Halberstadt, C., Naughton, G., Schwartz, R. et al., Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J. Biomed. Mater. Res. 1997, 34, 211-220.
38. Abrahamsson, C. K., Yang, F., Park, H., Brunger, J. M. et al., Chondrogenesis and mineralization during in vitro culture of human mesenchymal stem cells on three-dimensional woven scaffolds. Tissue Eng. A. 2010, 16, 3709-3718.
39. Chung, J. E., Yokoyama, M., Yamato, M., Aoyagi, T. et al., Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). J. Control. Release 1999, 62, 115-127.
40. Mohajeri, S., Hosseinkhani, H., Ebrahimi, N. G., Nikfarjam, L. et al., Proliferation and differentiation of mesenchymal stem cell on collagen sponge reinforced with polypropylene/polyethylene terephthalate blend fibers. Tissue Eng. A. 2010, 16, 3821-3830.
41. Moroni, L., Curti, M., Welti, M., Korom, S. et al., Anatomical 3D fiber-deposited scaffolds for tissue engineering: designing a neotrachea. Tissue Eng. 2007, 13, 2483-2493.
42. Caplan, A. I., Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol. 2007, 213, 341-347.
43. Petite, H., Viateau, V., Bensaïd, W., Meunier, A. et al., Tissue-engineered bone regeneration. Nat. Biotechnol. 2000, 18, 959-963.
44. Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E. et al., Growth factors in bone matrix. J. Biol. Chem. 1986, 261, 12665-12674.
45. Lee, K., Silva, E. A., Mooney, D. J., Growth factor delivery-based tissue engineering: General approaches and a review of recent developments. J. R. Soc. Interface. 2011, 8, 153-170.
46. Chen, F-M., Zhang, M., Wu, Z-F., Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31, 6279-6308.
47. Ma, P. X., Elisseeff, J., Scaffolding in tissue engineering. CRC Press, Boca Raton, 2006.
48. Holt, C. E., Harris, W. A., Target selection: invasion, mapping and cell choice, Curr. Opin. Neurobiol. 1998, 8, 98-105.
49. Key, B., St John, J., Axon navigation in the mammalian primary olfactory pathway: where to next? Chem. Senses 2002, 27, 245-260.
50. McDonald, J. W., Liu, X.-Z., Qu, Y., Liu, S. et al., Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 1999, 5, 1410-1412.
51. Xu, X. M., Guénard, V., Kleitman, N., Aebischer, P. et al., A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp. Neurol. 1995, 134, 261-272.
52. Griffith, L. G., Naughton, G., Tissue Engineering - current challenges and expanding opportunities. Science 2002, 295, 1009-1014.
53. MacNeil, S., Progress and opportunities for tissue-engineered skin. Nature 2007, 445, 874-880.
54. Matsumoto, T., Holmes, R. H., Burdick, C. O., Metzger, J. F. et al., A study of inverted intestinal graft in the major veins. Angiology 1966, 17, 842-850.
55. Pankajakshan, D., Agrawal, D. K., Scaffolds in tissue engineering of blood vessels. Can. J. Physiol. Pharmacol. 2010, 855-873.
56. Weinberg, C. B., Bell, E., A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231, 397-400.
57. L'Heureux, N., Germain, L., Labbé, R., Auger, F. A., In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J. Vasc. Surg. 1993, 17, 499-509.
58. Zorlutuna, P., Hasirci, N., Hasirci, V., Nanopatterned collagen tubes for vascular tissue engineering. J. Tissue Eng. Regen. Med. 2008, 2, 373-377.
59. Hinds, M. T., Rowe, R. C., Ren, Z., Teach, J. et al., Development of a reinforced porcine elastin composite vascular scaffold. J. Biomed. Mater. Res. A. 2006, 77, 458-469.
60. Kumar, T. R., Krishnan, L. K., A stable matrix for generation of tissue-engineered nonthrombogenic vascular grafts. Tissue Eng. 2002, 8, 763-770.
61. Remuzzi, A., Mantero, S., Colombo, M., Morigi, M. et al., Vascular smooth muscle cells on hyaluronic acid: culture and mechanical characterization of an engineered vascular construct. Tissue Eng. 2004, 10, 699-710.
62. Zhang, L., Ao, Q., Wang, A., Lu, G. et al., A sandwich tubular scaffold derived from chitosan for blood vessel tissue engineering. J. Biomed. Mat. Res. A. 2006, 277-284.
63. Shum-Tim, D., Stock, U., Hrkach, J., Shinoka, T. et al., Tissue engineering of autologous aorta using a new biodegradable polymer. Ann. Thorac. Surg. 1999, 68, 2298-2304.
64. Greisler, H. P., Kim, D. U., Price, J. B., Voorhee, A. B. Jr., Arterial regenerative activity after prosthetic implantation. Arch. Surg. 1985, 120, 315-323.
65. Xue, L., Greisler, H. P., Biomaterials in the development and future of vascular grafts. J. Vasc. Surg. 2003, 37, 472-480.
66. Tanzi, M. C., Fare, S., Petrini, P., In vitro stability of polyether and polycarbonate urethanes. J. Biomater. Appl. 2000, 14, 325-348.
67. Jeschke, M. G., Hermanutz, V., Wolf, S.E., Köveker, G. B., Polyurethane vascular prostheses decreases neointimal formation compared with expanded polytetrafluoroethylene. J. Vasc. Surg. 1999, 29, 168-176.
68. Nevo, Z., Robinson, D., Horowitz, S., Hasharoni, A., Yayon, A., The manipulated mesenchymal stem cells in regenerated skeletal tissues. Cell Transplant. 1998, 7, 63-70.
69. Grande, D., Southerland, S., Manji, R., Repair of articular cartilage defects using mesenchymal stem cells. Tissue Eng. 1995, 1, 345-353.
70. Takagi, M., Fukui, Y., Wakitani, S., Yoshida, T., Effect of poly DL-lactic-co-glycolic acid mesh on a three-dimensional culture of chondrocytes. J. Biosci. Bioeng. 2004, 98, 477-481.
71. Ando, W., Tateishi, K., Hart, D. A., Katakai, D. et al., Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 2007, 28, 5462-5470.
72. Marlovits, S., Brigitte, T., Michaela, T., Gruber, D. et al., Chondrogenesis of aged human articular cartilage in a scaffold-free bioreactor. Tissue Eng. 2003, 9, 1215-1226.
73. Park, K., Huang, J., Azar, F., Jin, R.L. et al., Scaffold-free, engineered porcine cartilage construct for cartilage defect repair - in vitro and in vivo study. Artif. Organs 2006, 30, 586-596.
74. Tsuchiya, K., Furukawa, K., Ushida, T., Microelements for cartilage tissue engineering, in: Wada, H. (Ed.), Biomechanics at micro-and nanoscale levels, vol. II., World Scientific, New Jersey, 2006, pp. 87-95.
75. Nagai, T., Furukawa, K. S., Sato, M., Ushida, T. et al., Characteristics of a scaffold-free articular chondrocyte plate grown in rotational culture. Tissue Eng. A. 2008, 14, 1183-1193.
76. Yang, J., Yamato, M., Shimizu, T., Sekine, H. et al., Reconstruction of functional tissues with cell sheet engineering. Biomaterials 2007, 28, 5033-5043.
77. Okano, T., Yamada, N., Sakai, H., Sakurai, Y., A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J. Biomed. Mater. Res. 1993, 27, 1243-1251.
78. Sekiya, S., Shimizu, T., Yamato, M., Kikuchi, A. et al., Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. Biochem. Biophys. Res. Commun. 2006, 341, 573-582.
79. Kaneshiro, N., Sato, M., Ishihara, M., Mitani, G. et al., Bioengineered chondrocyte sheets may be potentially useful for the treatment of partial thickness defects of articular cartilage. Biochem. Biophys. Res. Commun. 2006, 349, 723-731.
80. Gruene, M., Deiwick, A., Koch, L., Schlie, S. et al., Laser printing of stem cells for biofabrication of scaffold-free autologous grafts. Tissue Eng. C Methods 2010, 17, 79-87.
81. Akahane, M., Shigematsu, H., Tadokoro, M., Ueha, T. et al., Scaffold-free cell sheet injection results in bone formation. J. Tissue Eng. Regen. Med. 2010, 4, 404-411.
82. Gurkan, U. A., Kishore, V., Condon, K. W., Bellido, T. M. et al., A scaffold-free multicellular three-dimensional in vitro model of osteogenesis. Calcif. Tissue Int. 2011, 88, 388-401.
83. Radtke, C., Vogt, P. M., Peripheral nerve regeneration: a current perspective. Eplasty 2009, e47.
84. Li, Y., Decherchi, P., Raisman, G., Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J. Neurosci. 2003, 23, 727-731.
85. Cao, Q.L., Zhang, Y.P., Howard, R. M., Walters, W.M. et al., Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp. Neurol. 2001, 167, 48-58.
86. Radtke, C., Redeker, J., Jokuszies, A., Vogt, P. M., In vivo transformation of neural stem cells following transplantation in the injured nervous system, J. Reconstr. Microsurg. 2010, 211-212.
87. Bjorklund, L. M., Sanchez-Pernaute, R., Chung, S., Andersson, T. et al., Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA 2002, 99, 2344-2349.
88. Koshizuka, S., Okada, S., Okawa, A., Koda, M. et al., Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J. Neuropathol. Exp. Neurol. 2004, 63, 64-72.
89. Hofstetter, C. P., Holmström, N. A. V., Lilja, J. A., Schweinhardt, P. et al., Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci. 2005, 8, 346-353.
90. Watanabe, K., Kamiya, D., Nishiyama, A., Katayama, T. et al., Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 2005, 288-296.
91. Sheyn, D., Mizrahi, O., Benjamin, S., Gazit, Z. et al., Genetically modified cells in regenerative medicine and tissue engineering. Adv. Drug Deliver. Rev. 2010, 62, 683-698.
92. Sakowski, S. A., Heavener, S. B., Lunn, J. S., Fung, K. et al., Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Gene Ther. 2009, 16, 1292-1299.
93. Blakemore, W. F., Franklin, R. J., Transplantation options for therapeutic central nervous system remyelination. Cell Transplant. 2000, 9, 289-294.
94. Papastefanaki, F., Chen, J., Lavdas, A. A., Thomaidou, D. et al., Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury. Brain 2007, 130, 2159-2174.
95. Renner, R., Harth, W., Simon, J. C., Transplantation of chronic wounds with epidermal sheets derived from autologous hair follicles - the Leipzig experience. Int. Wound J. 2009, 6, 226-232.
96. Swope, V. B., Supp, A. P., Cornelius, J. R., Babcock, G. F. et al., Regulation of pigmentation in cultured skin substitutes by cytometric sorting of melanocytes and keratinocytes. J. Invest. Dermatol. 1997, 109, 289-295.
97. Havlickova, B., Biro, T., Mescalchin, A., Tschirschmann, M. et al., A human folliculoid microsphere assay for exploring epithelial-mesenchymal interactions in the human hair follicle. J. Invest. Dermatol. 2009, 129, 972-983.
98. Nor, J. E., Peters, M. C., Christensen, J. B., Sutorik, M. M. et al., Engineering and characterization of functional human microvessels in immunodeficient mice. Lab. Invest. 2001, 81, 453-463.
99. Inaba, S., Egashira, K., Komori, K., Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? Lancet 2002, 360, 2083.
100. L'Heureux, N., Pâquet, S., Labbé, R., Germain, L. et al., A completely biological tissue-engineered human blood vessel. FASEB J. 1998, 12, 47-56.
101. Norotte, C., Marga, F. S., Niklason, L. E., Forgacs, G., Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 2009, 5910-5917.
102. Arnesen, H., Lunde, K., Aakhus, S., Forfang, K., Cell therapy in myocardial infarction. Lancet 2007, 369, 2142-2143.
103. Ito, A., Ino, K., Kobayashi, T., Honda, H., The effect of RGD peptide-conjugated magnetite cationic liposomes on cell growth and cell sheet harvesting. Biomaterials 2005, 26, 6185-619.
104. Zhang, M., Mal, N., Kiedrowski, M., Chacko, M. et al., SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007, 21, 3197-3207.